The antiserum was produced against synthesized peptide derived from human Bax around the phosphorylation site of Thr167. AA range:133-182

Phospho-Bax (T167) Polyclonal Antibody detects endogenous levels of Bax protein only when phosphorylated at T167.The name of modified sites may be influenced by many factors, such as species (the modified site was not originally found in human samples) and the change of protein sequence (the previous protein sequence is incomplete, and the protein sequence may be prolonged with the development of protein sequencing technology). When naming, we will use the "numbers" in historical reference to keep the sites consistent with the reports. The antibody binds to the following modification sequence (lowercase letters are modification sites):FGtPT

BAX

Apoptosis regulator BAX

BAX ;
BCL2L4 ;
Apoptosis regulator BAX ;
Bcl-2-like protein 4 ;
Bcl2-L-4

The protein encoded by BAX (BCL2 associated X , apoptosis regulator) belongs to the BCL2 protein family. BCL2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. This protein forms a heterodimer with BCL2 , and functions as an apoptotic activator. This protein is reported to interact with , and increase the opening of , the mitochondrial voltage-dependent anion channel (VDAC) , which leads to the loss in membrane potential and the release of cytochrome c. The expression of this gene is regulated by the tumor suppressor P53 and has been shown to be involved in P53-mediated apoptosis. Multiple alternatively spliced transcript variants , which encode different isoforms , have been reported for BAX.

Disease:Defects in BAX are found in some cell lines from hematopoietic malignancies as T-cell acute lymphoblastic leukemia , Burkitt lymphoma , and plasmacytoma. ,Domain:Intact BH3 motif is required by BIK , BID , BAK , BAD and BAX for their pro-apoptotic activity and for their interaction with anti-apoptotic members of the Bcl-2 family. ,Function:Accelerates programmed cell death by binding to , and antagonizing the apoptosis repressor BCL2 or its adenovirus homolog E1B 19k protein. Induces the release of cytochrome c , activation of CASP3 , and thereby apoptosis. ,similarity:Belongs to the Bcl-2 family. ,subcellular location:Colocalizes with 14-3-3 proteins in the cytoplasm. Under stress conditions , redistributes to the mitochondrion membrane through the release from JNK-phosphorylated 14-3-3 proteins. ,subunit:Homodimer. Forms heterodimers with BCL2 , E1B 19K protein , BCL2L1 isoform Bcl-X (L) , MCL1 and A1. Interacts with SH3GLB1 and HN. Interacts with SFN and YWHAZ; the interaction occurs in the cytoplasm. Under stress conditions , JNK-mediated phosphorylation of SFN and YWHAZ , releases BAX to mitochondria. Isoform Sigma interacts with BCL2A1 and BCL2L1 isoform Bcl-X (L) . ,tissue specificity:Expressed in a wide variety of tissues. Isoform Psi is found in glial tumors. Isoform Alpha is expressed in spleen , breast , ovary , testis , colon and brain , and at low levels in skin and lung. Isoform Sigma is expressed in spleen , breast , ovary , testis , lung , colon , brain and at low levels in skin. Isoform Alpha and isoform Sigma are expressed in pro-myelocytic leukemia , histyocytic lymphoma , Burkitt's lymphoma , T-cell lymphoma , lymphoblastic leukemia , breast adenocarcinoma , ovary adenocarcinoma , prostate carcinoma , prostate adenocarcinoma , lung carcinoma , epidermoid carcinoma , small cell lung carcinoma and colon adenocarcinoma cell lines. ,

[Isoform Alpha]: Mitochondrion outer membrane ; Single-pass membrane protein . Cytoplasm . Colocalizes with 14-3-3 proteins in the cytoplasm. Under stress conditions , undergoes a conformation change that causes release from JNK-phosphorylated 14-3-3 proteins and translocation to the mitochondrion membrane. Upon Sendai virus infection , recruited to the mitochondrion through interaction with IRF3 (PubMed:25609812) . .; [Isoform Beta]: Cytoplasm.; [Isoform Gamma]: Cytoplasm.; [Isoform Delta]: Cytoplasm .

>>EGFR tyrosine kinase inhibitor resistance ;
>>Endocrine resistance ;
>>Platinum drug resistance ;
>>Sphingolipid signaling pathway ;
>>p53 signaling pathway ;
>>Protein processing in endoplasmic reticulum ;
>>Apoptosis ;
>>Longevity regulating pathway ;
>>Apoptosis - multiple species ;
>>Necroptosis ;
>>Neurotrophin signaling pathway ;
>>Non-alcoholic fatty liver disease ;
>>AGE-RAGE signaling pathway in diabetic complications ;
>>Parkinson disease ;
>>Amyotrophic lateral sclerosis ;
>>Huntington disease ;
>>Prion disease ;
>>Pathways of neurodegeneration - multiple diseases ;
>>Pathogenic Escherichia coli infection ;
>>Shigellosis ;
>>Salmonella infection ;
>>Tuberculosis ;
>>Hepatitis C ;
>>Hepatitis B ;
>>Measles ;
>>Human cytomegalovirus infection ;
>>Influenza A ;
>>Human papillomavirus infection ;
>>Human T-cell leukemia virus 1 infection ;
>>Kaposi sarcoma-associated herpesvirus infection ;
>>Herpes simplex virus 1 infection ;
>>Epstein-Barr virus infection ;
>>Human immunodeficiency virus 1 infection ;
>>Pathways in cancer ;
>>Transcriptional misregulation in cancer ;
>>Viral carcinogenesis ;
>>Colorectal cancer ;
>>Pancreatic cancer ;
>>Endometrial cancer ;
>>Glioma ;
>>Thyroid cancer ;
>>Basal cell carcinoma ;
>>Melanoma ;
>>Chronic myeloid leukemia ;
>>Small cell lung cancer ;
>>Non-small cell lung cancer ;
>>Breast cancer ;
>>Hepatocellular carcinoma ;
>>Gastric cancer ;
>>Lipid and atherosclerosis